You are here: Industry Insights > SARS-CoV-2

News List

Seven Cases of Guillain-Barré Noted After COVID-19 Vaccine in India drugs
June 29, 2021
Cases of Guillain-Barré syndrome (GBS) have been reported after receipt of the Oxford-AstraZeneca severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine, according to two reports published online June 10 in the Annals of Neurology.
Junshi Biosciences Sinks After US Halts Chinese Firm’s Covid-19 Antibody Therapy firstwordpharma
June 29, 2021
Junshi Biosciences' shares fell as much as 4% after the drugmaker confirmed that distribution of its antibody combination therapy for COVID-19, developed with Eli Lilly, has been suspended in the US, as reported Yicai Global on Monday.
Vazyme Brings COVID-19 Testing Solutions at Medlab 2021 prnewswire
June 28, 2021
Chinese biotechnology company Nanjing Vazyme Biotech Co., Ltd (Vazyme) showcased its lineup of COVID-19 testing solutions and its point-of-care testing (POCT) in vitro diagnostic instruments at the 2021 Medlab Middle East.
Coronavirus (COVID-19) Update: FDA Authorizes Drug for Treatment of COVID-19 fda.gov
June 28, 2021
Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the drug Actemra (tocilizumab) for the treatment of hospitalized adults and pediatric patients (2 years of age and older)
Virus that causes COVID-19 can find alternate route to infect cells worldpharmanews
June 25, 2021
Early in the COVID-19 pandemic, scientists identified how SARS-CoV-2, the virus that causes COVID-19, gets inside cells to cause infection.
Lost Sense of Smell Returns for Almost All COVID Survivors drugs
June 25, 2021
A year on, nearly all patients in a French study who lost their sense of smell after a bout of COVID-19 did regain that ability, researchers report.
Duke-NUS and GenScript Announce Notice of Allowance for U.S. Patent Application for SARS-CoV-2 Surrogate Virus Neutralization Test prnasia
June 22, 2021
GenScript Biotech Corporation announced that the U.S. Patent and Trade Office has issued a notice of allowance for the patent application for a novel Surrogate Virus Neutralization Technology (sVNT).
Not-So-Happy-Birthdays: Parties Helped Spread COVID, Study Finds drugs
June 22, 2021
Birthday celebrations raised the risk of spreading SARS-CoV-2 by 30% last year in U.S. counties with high rates of COVID-19, according to a new study. No such surge was seen in places with low rates of infection.
COVID-19 dual-antibody therapies effective against variants in animal study firstwordpharma
June 22, 2021
COVID-19 therapies made from antibodies often are given to patients who are at high risk of severe illness and hospitalization.
Latest testing confirms Viraleze highly effective against Alpha, Beta and Gamma COVID variants prnasia
June 18, 2021
New data released today shows that Australia's Viraleze™ anti-COVID nasal spray is more than 99.9% effective against three of the four deadliest variants of the SARS-CoV-2 virus.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 61 62 Next page